Great Lakes Advisors’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.59M Sell
273,489
-420,001
-61% -$11M 0.05% 191
2026
Q1
$19.5M Buy
693,490
+173,207
+33% +$4.61M 0.16% 112
2025
Q4
$13M Buy
520,283
+477,525
+1,117% +$12M 0.11% 138
2025
Q3
$1.09M Buy
42,758
+13,865
+48% +$342K 0.01% 518
2025
Q2
$700K Sell
28,893
-51,490
-64% -$1.2M 0.01% 567
2025
Q1
$2.04M Buy
80,383
+63,670
+381% +$1.67M 0.02% 438
2024
Q4
$443K Sell
16,713
-886
-5% -$24K ﹤0.01% 669
2024
Q3
$509K Sell
17,599
-494
-3% -$14.4K ﹤0.01% 655
2024
Q2
$506K Buy
18,093
+4,658
+35% +$128K ﹤0.01% 652
2024
Q1
$373K Sell
13,435
-232
-2% -$6.44K ﹤0.01% 658
2023
Q4
$393K Sell
13,667
-6,644
-33% -$201K ﹤0.01% 639
2023
Q3
$674K Buy
20,311
+6,308
+45% +$223K 0.01% 574
2023
Q2
$514K Sell
14,003
-34,706
-71% -$1.35M 0.01% 596
2023
Q1
$1.99M Buy
48,709
+1,272
+3% +$54.9K 0.02% 502
2022
Q4
$2.43M Buy
47,437
+26,809
+130% +$1.29M 0.14% 252
2022
Q3
$903K Buy
20,628
+1,443
+8% +$70.1K 0.02% 422
2022
Q2
$1.01M Sell
19,185
-2,407
-11% -$123K 0.02% 431
2022
Q1
$1.12M Sell
21,592
-2,404
-10% -$125K 0.02% 436
2021
Q4
$1.42M Sell
23,996
-254
-1% -$12.6K 0.02% 414
2021
Q3
$1.04M Buy
24,250
+1,962
+9% +$86.9K 0.02% 448
2021
Q2
$873K Sell
22,288
-316
-1% -$12.3K 0.01% 463
2021
Q1
$819K Sell
22,604
-1,062
-4% -$37.7K 0.01% 467
2020
Q4
$871K Sell
23,666
-1,202
-5% -$44.1K 0.02% 436
2020
Q3
$866K Buy
24,868
+541
+2% +$19K 0.02% 413
2020
Q2
$755K Sell
24,327
-1,413
-5% -$48K 0.02% 411
2020
Q1
$797K Sell
25,740
-2,643
-9% -$90.1K 0.02% 396
2019
Q4
$1.05M Sell
28,383
-37
-0.1% -$1.32K 0.02% 385
2019
Q3
$969K Sell
28,420
-71,441
-72% -$2.6M 0.02% 390
2019
Q2
$4.11M Sell
99,861
-144,551
-59% -$5.74M 0.09% 235
2019
Q1
$9.85M Sell
244,412
-153,167
-39% -$6.13M 0.22% 110
2018
Q4
$16.5M Buy
397,579
+173,648
+78% +$7.21M 0.39% 58
2018
Q3
$9.36M Buy
223,931
+198,247
+772% +$7.63M 0.21% 111
2018
Q2
$884K Sell
25,684
-282
-1% -$9.64K 0.02% 392
2018
Q1
$874K Sell
25,966
-12,247
-32% -$421K 0.02% 384
2017
Q4
$1.31M Sell
38,213
-15,149
-28% -$517K 0.03% 361
2017
Q3
$1.81M Sell
53,362
-3,738
-7% -$120K 0.04% 319
2017
Q2
$1.82M Sell
57,100
-6,158
-10% -$194K 0.04% 301
2017
Q1
$2.05M Sell
63,258
-322,276
-84% -$10.2M 0.05% 266
2016
Q4
$11.9M Buy
385,534
+14,637
+4% +$447K 0.31% 60
2016
Q3
$11.9M Sell
370,897
-19,584
-5% -$655K 0.32% 56
2016
Q2
$13M Buy
390,481
+40,169
+11% +$1.28M 0.36% 57
2016
Q1
$9.85M Buy
350,312
+64,878
+23% +$1.85M 0.27% 65
2015
Q4
$8.74M Buy
285,434
+182,885
+178% +$5.75M 0.26% 69
2015
Q3
$3.06M Sell
102,549
-1,937
-2% -$62.1K 0.09% 183
2015
Q2
$3.32M Sell
104,486
-24,310
-19% -$792K 0.1% 175
2015
Q1
$4.25M Buy
128,796
+38,235
+42% +$1.22M 0.13% 129
2014
Q4
$2.68M Sell
90,561
-51,264
-36% -$1.47M 0.08% 177
2014
Q3
$3.98M Buy
141,825
+41,355
+41% +$1.16M 0.13% 122
2014
Q2
$2.83M Buy
100,470
+4,950
+5% +$141K 0.12% 95
2014
Q1
$2.91M Sell
95,520
-2,277
-2% -$67.9K 0.13% 95
2013
Q4
$2.84M Sell
97,797
-127,072
-57% -$3.7M 0.13% 81
2013
Q3
$6.13M Sell
224,869
-4,706
-2% -$128K 0.28% 61
2013
Q2
$6.1M Buy
+229,575
New +$6.34M 0.29% 61

Other funds holding PFE

Great Lakes Advisors's PFE Position: Q2 2026 in Review

Great Lakes Advisors reduced its Pfizer (PFE) stake by 61% in Q2 2026, selling an estimated $11M and leaving 273,489 shares worth $6.59M. The position accounts for 0.05% of the portfolio, ranked #191.

Great Lakes Advisors first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $19.5M in Q1 2026. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Great Lakes Advisors held 273,489 shares of Pfizer worth $6.59M as of Q2 2026.
  • Great Lakes Advisors sold 420,001 Pfizer shares in Q2 2026, an estimated $11M.
  • Pfizer made up 0.05% of Great Lakes Advisors's portfolio in Q2 2026, its #191 holding.
  • Great Lakes Advisors first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
  • Great Lakes Advisors's Pfizer position peaked at $19.5M in Q1 2026.
  • 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Great Lakes Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.